Sensitivity studies of L-dopa metabolites in reserpinized rats and their clinical significance.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002396:Catechols / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000378:metabolism* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000627:therapeutic use*; D008875:Middle Aged; D009048:Motor Skills; D009069:Movement Disorders / Q000139:chemically induced* / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D010648:Phenylacetates / Q000378:metabolism / Q000627:therapeutic use*; D051381:Rats; D012110:Reserpine; D014642:Vanilmandelic Acid / Q000378:metabolism
D002396:Catechols; D008333:Mandelic Acids; D010648:Phenylacetates; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D012110:Reserpine